SCHEMBL7983379

SCHEMBL7983379

Fc1ccc2nc(Nc3c(Cl)cccc3Cl)c3cncn3c2c1

nearest known ligand 0.85

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LCK P06239 20/20 0.85

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7969550 0.92 LCK (1.00) LCK
SCHEMBL7982128 0.84 LCK (1.00) LCK
SCHEMBL7983230 0.83 LCK (0.77) LCK
SCHEMBL7970311 0.83 LCK (0.88) LCK
SCHEMBL7981245 0.81 LCK (1.00) LCK
SCHEMBL7983615 0.80 LCK (0.80) LCK
SCHEMBL7980799 0.79 LCK (0.88) LCK
SCHEMBL7970675 0.79 LCK (0.81) LCK
SCHEMBL8469975 0.79 LCK (0.80) LCK
SCHEMBL7983566 0.79 LCK (1.00) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed